{"id":"https://openalex.org/W2015540146","doi":"https://doi.org/10.1177/1087057112456874","title":"Translation of a Tumor Microenvironment Mimicking 3D Tumor Growth Co-culture Assay Platform to High-Content Screening","display_name":"Translation of a Tumor Microenvironment Mimicking 3D Tumor Growth Co-culture Assay Platform to High-Content Screening","alternate_titles":[],"publication_year":2012,"publication_date":"2012-08-25","ids":{"openalex":"https://openalex.org/W2015540146","doi":"https://doi.org/10.1177/1087057112456874","mag":"2015540146","pmid":"https://pubmed.ncbi.nlm.nih.gov/22923784"},"language":"en","primary_location":{"id":"doi:10.1177/1087057112456874","doi":"https://doi.org/10.1177/1087057112456874","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057112456874","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1087057112456874","source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2015540146"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/1087057112456874","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066571505","display_name":"Eberhard Krausz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Eberhard Krausz","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium. ekrausz@its.jnj.com","Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium. ekrausz@its.jnj.com","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054702093","display_name":"Ronald De Hoogt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ronald de Hoogt","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026129104","display_name":"Emmanuel M. Gustin","orcid":"https://orcid.org/0000-0002-7606-1075","observed_orcids":["https://orcid.org/0000-0002-7606-1075"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emmanuel Gustin","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055183223","display_name":"Frans W. Cornelissen","orcid":"https://orcid.org/0000-0002-5144-9700","observed_orcids":["https://orcid.org/0000-0002-5144-9700"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frans Cornelissen","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048982975","display_name":"Thierry Grand\u2010Perret","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thierry Grand-Perret","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056497240","display_name":"Lut Janssen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lut Janssen","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020869060","display_name":"Nele Vloemans","orcid":"https://orcid.org/0009-0002-9483-9271","observed_orcids":["https://orcid.org/0009-0002-9483-9271"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nele Vloemans","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109877824","display_name":"Dirk Wuyts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dirk Wuyts","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062222020","display_name":"Sandy Frans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandy Frans","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081535062","display_name":"Amy E. Axel","orcid":"https://orcid.org/0009-0000-7039-3469","observed_orcids":["https://orcid.org/0009-0000-7039-3469"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy Axel","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004552137","display_name":"Pieter Johan Peeters","orcid":"https://orcid.org/0000-0002-3295-1164","observed_orcids":["https://orcid.org/0000-0002-3295-1164"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pieter Johan Peeters","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114046165","display_name":"Brett M. Hall","orcid":"https://orcid.org/0009-0001-2290-0814","observed_orcids":["https://orcid.org/0009-0001-2290-0814"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brett Hall","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063277070","display_name":"Miroslav Cik","orcid":"https://orcid.org/0000-0003-0036-7032","observed_orcids":["https://orcid.org/0000-0003-0036-7032"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Miroslav Cik","raw_affiliation_strings":["Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"1Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5066571505"],"corresponding_institution_ids":["https://openalex.org/I137982388"],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":{"value":2070,"currency":"USD","value_usd":2070},"fwci":2.316,"has_fulltext":true,"cited_by_count":70,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90646327,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"18","issue":"1","first_page":"54","last_page":"66"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12859","display_name":"Cell Image Analysis Techniques","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/1304","display_name":"Biophysics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12859","display_name":"Cell Image Analysis Techniques","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/1304","display_name":"Biophysics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9940000176429749},{"id":"https://openalex.org/keywords/three-dimensional-co-culture","display_name":"3D co-culture","score":0.8489999771118164},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.8920000195503235},{"id":"https://openalex.org/keywords/high-content-screening","display_name":"high-content screening","score":0.9710000157356262},{"id":"https://openalex.org/keywords/automated-microscopy","display_name":"automated microscopy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/confocal-microscopy","display_name":"confocal microscopy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/image-analysis","display_name":"image analysis","score":0.675000011920929},{"id":"https://openalex.org/keywords/anticancer-drug-screening","display_name":"anticancer drug screening","score":0.890999972820282},{"id":"https://openalex.org/keywords/assay-throughput","display_name":"assay throughput","score":0.375},{"id":"https://openalex.org/keywords/cell-based-assays","display_name":"cell-based assays","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6615862250328064},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5681334137916565},{"id":"https://openalex.org/C74318829","wikidata":"https://www.wikidata.org/wiki/Q36458","display_name":"Multicellular organism","level":3,"score":0.564805805683136},{"id":"https://openalex.org/C157044486","wikidata":"https://www.wikidata.org/wiki/Q5754482","display_name":"High-content screening","level":3,"score":0.5594696402549744},{"id":"https://openalex.org/C163688615","wikidata":"https://www.wikidata.org/wiki/Q15883629","display_name":"3D cell culture","level":3,"score":0.5456280708312988},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.4897213280200958},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.47306787967681885},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.45853716135025024},{"id":"https://openalex.org/C2988629283","wikidata":"https://www.wikidata.org/wiki/Q44337","display_name":"Complex matrix","level":2,"score":0.45037969946861267},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.44996872544288635},{"id":"https://openalex.org/C2779178360","wikidata":"https://www.wikidata.org/wiki/Q902045","display_name":"Confocal microscopy","level":2,"score":0.44671958684921265},{"id":"https://openalex.org/C149364088","wikidata":"https://www.wikidata.org/wiki/Q185917","display_name":"Translation (biology)","level":4,"score":0.44670283794403076},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3842830955982208},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.368664026260376},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3127898871898651},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.28851526975631714},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2672766447067261},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2507162094116211},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13572588562965393},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.1147925853729248},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10565117001533508},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007091","descriptor_name":"Image Processing, Computer-Assisted","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012015","descriptor_name":"Reference Standards","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018920","descriptor_name":"Coculture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D059630","descriptor_name":"Mesenchymal Stem Cells","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D059630","descriptor_name":"Mesenchymal Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/1087057112456874","doi":"https://doi.org/10.1177/1087057112456874","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057112456874","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1087057112456874","source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},{"id":"pmid:22923784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22923784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biomolecular screening","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/1087057112456874","doi":"https://doi.org/10.1177/1087057112456874","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057112456874","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1087057112456874","source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2015540146.pdf","grobid_xml":"https://content.openalex.org/works/W2015540146.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W201784232","https://openalex.org/W1501344851","https://openalex.org/W1964976936","https://openalex.org/W1979976356","https://openalex.org/W1991001144","https://openalex.org/W2004403900","https://openalex.org/W2010251891","https://openalex.org/W2018185888","https://openalex.org/W2029108033","https://openalex.org/W2031598641","https://openalex.org/W2037664310","https://openalex.org/W2056229778","https://openalex.org/W2058727957","https://openalex.org/W2062265555","https://openalex.org/W2070262049","https://openalex.org/W2072303914","https://openalex.org/W2088335906","https://openalex.org/W2107620713","https://openalex.org/W2114229735","https://openalex.org/W2119975980","https://openalex.org/W2129889641","https://openalex.org/W2140474512","https://openalex.org/W2140723257","https://openalex.org/W2144834034","https://openalex.org/W2167407535"],"related_works":["https://openalex.org/W4393086168","https://openalex.org/W2562290458","https://openalex.org/W4413094680","https://openalex.org/W2132539166","https://openalex.org/W2066906765","https://openalex.org/W4206337522","https://openalex.org/W4225096494","https://openalex.org/W3022119795","https://openalex.org/W1538333208","https://openalex.org/W4317359076"],"abstract_inverted_index":{"For":[0],"drug":[1],"discovery,":[2],"cell-based":[3],"assays":[4,63],"are":[5],"becoming":[6],"increasingly":[7],"complex":[8,56,62],"to":[9,36,53,82,100],"mimic":[10],"more":[11,37],"realistically":[12],"the":[13,40,43,50],"nature":[14],"of":[15,42],"biological":[16,57],"processes":[17],"and":[18,85,104],"their":[19],"diversifications":[20],"in":[21,26,34,118,130],"diseases.":[22],"Multicellular":[23],"co-cultures":[24],"embedded":[25],"a":[27,68,76],"three-dimensional":[28],"(3D)":[29],"matrix":[30],"have":[31,125],"been":[32,116,126],"explored":[33],"oncology":[35],"closely":[38],"approximate":[39],"physiology":[41],"human":[44],"tumor":[45,78],"microenvironment.":[46],"High-content":[47],"analysis":[48,98],"is":[49,67],"ideal":[51],"technology":[52],"characterize":[54],"these":[55],"systems,":[58],"although":[59],"running":[60],"such":[61],"at":[64],"higher":[65],"throughput":[66],"major":[69],"endeavor.":[70],"Here,":[71],"we":[72,86],"report":[73],"on":[74],"adapting":[75],"3D":[77],"co-culture":[79],"growth":[80],"assay":[81],"automated":[83,96],"microscopy,":[84],"compare":[87],"various":[88],"imaging":[89],"platforms":[90],"(confocal":[91],"vs.":[92],"nonconfocal)":[93],"with":[94],"correlating":[95],"image":[97],"solutions":[99],"identify":[101],"optimal":[102],"conditions":[103],"settings":[105],"for":[106,128],"future":[107],"larger":[108],"scaled":[109],"screening":[110],"campaigns.":[111],"The":[112],"optimized":[113],"protocol":[114],"has":[115],"validated":[117],"repeated":[119],"runs":[120],"where":[121],"established":[122],"anticancer":[123],"drugs":[124],"evaluated":[127],"performance":[129],"this":[131],"innovative":[132],"assay.":[133]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2015540146","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
